Company News | Oct. 3, 2016
RxData helps life science companies make sense of the tremendous amount of market access information available New York, NY - 10/03/2016 RxData (RxData, Inc.), the leading provider of comprehensive global market access data, has chosen FDB (First Databank, Inc.) as its supplier of U.S. commercial drug pricing information. FDB is the leading provider of clinical drug knowledge that helps improve medication-related decisions and patient outcomes. Lawrence Monoson, CEO of RxData, comments, “We are very happy to work alongside FDB for this very useful information, which includes the sought-after U.S. WAC prices.” The Wholesale Acquisition Cost (WAC) as published by FDB represents the manufacturer's (includes manufacturers, repackagers, private labelers and other suppliers) published catalog or list price for a drug product to wholesalers as reported to FDB. RxData has already integrated this drug pricing information into its powerful SaaS platform. Leveraging its data models, users are able to search and compare treatment costs in the United States across all therapeutic areas. “Never before has it been this easy for life sciences organizations to understand the global market access environment, and adding this data is a non-trivial piece of the puzzle,” says Monoson. About RxData, Inc. (RxData) RxData, with operations in the U.S.A. and Switzerland, is a leading global market access data company, providing fast and reliable insights on life science commercialization. With the largest on-demand and automated database of pharmaceutical product prices and reimbursement decisions, it has never been easier to navigate the many complexities facing pharmaceutical commercialization. RxData empowers life science companies of all sizes to go-to-market faster, plan launches, price products and steer clinical and HEOR teams towards the best possible worldwide access. About First Databank (FDB) FDB (First Databank), part of the Hearst Health network, is the leading provider of drug knowledge that helps healthcare professionals make precise medication-related decisions. With thousands of customers worldwide, FDB enables our information system developer partners to deliver a wide range of valuable, useful, and differentiated solutions. As the company that virtually launched the medication decision support category, we offer more than three decades of experience in transforming drug knowledge into actionable, targeted, and effective solutions that improve patient safety and healthcare outcomes. For a complete look at our solutions and services please visit www.fdbhealth.com or follow us on Twitter and LinkedIn. CONTACT: RxData 646-427-4465 info@rxdata.net First Databank (FDB) Denise Apcar 650-872-4514 dapcar@fdbhealth.com © 2016 RxData, Inc. © 2016 First Databank, Inc. Part of the Hearst Health network. All trademarks mentioned herein are the properties of their respective owners.
